Pancreas
Research Hotspot & Journal Scope - Resectable
Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis
Jordan M Cloyd · Hsiang-Chun Chen · Xuemei Wang · Ching-Wei D Tzeng · Michael P Kim · Thomas A Aloia · Jean-Nicolas Vauthey · Jeffrey E Lee · Matthew H G Katz ·
MedicineSignificance of Lymph Node Metastasis in Resectable Well-differentiated Pancreatic Neuroendocrine Tumor
Norifumi Harimoto · Kouki Hoshino · Ryo Muranushi · Kei Hagiwara · Takahiro Yamanaka · Norihiro Ishii · Mariko Tsukagoshi · Takamichi Igarashi · Hiroshi Tanaka · Akira Watanabe · Norio Kubo · Kenichirou Araki · Yasuo Hosouchi · Hideki Suzuki · Kazuhisa Arakawa · Keitarou Hirai · Takaharu Fukazawa · Hayato Ikota · Ken Shirabe ·
MedicinePerformance of a Multidisciplinary Pancreatic Cancer Conference in Predicting and Managing Resectable Pancreatic Cancer
Bharat Rao · Aslam Syed · Shailendra Singh · Abhishek Gulati · Ghita Moussiade · Mrinal Garg · Manav Sharma · Suzanne Morrissey · Harry Williams · Donald Atkinson · Suzanne Schiffman · Dulabh Monga · Anthony Lupetin · Alexander Kirichenko · Marcia Mitre · Amy Tang · Manish Dhawan · Abhijit Kulkarni · Shyam Thakkar ·
MedicineBenefit of Gemcitabine/Nab-Paclitaxel Rescue of Patients With Borderline Resectable or Locally Advanced Pancreatic Adenocarcinoma After Early Failure of FOLFIRINOX
Timothy J Vreeland · Florencia McAllister · Sanaz Javadi · Laura R Prakash · David R Fogelman · Linus Ho · Gauri Varadhachary · Thomas A Aloia · Jean-Nicolas Vauthey · Jeffrey E Lee · Michael P Kim · Matthew H G Katz · Ching-Wei D Tzeng ·
MedicineComparative Study Between Gemcitabine-Based and Gemcitabine Plus S1–Based Preoperative Chemoradiotherapy for Localized Pancreatic Ductal Adenocarcinoma, With Special Attention to Initially Locally Advanced Unresectable Tumor
Taijiro Takeuchi · Shugo Mizuno · Yasuhiro Murata · Aoi Hayasaki · Masashi Kishiwada · Takehiro Fujii · Yusuke Iizawa · Hiroyuki Kato · Akihiro Tanemura · Naohisa Kuriyama · Yoshinori Azumi · Masanobu Usui · Hiroyuki Sakurai · Shuji Isaji ·
Medicine626Background: First line of RAS wild-type (WT) unresectable metastatic colorectal cancer (mCRC) can be doublet chemotherapy with an anti-VEGF (Vascular Endothelial Growth Factor), or an anti-EGFR.
ABSTRACT Background: Transarterial radioembolization (TARE) is used to treat unresectable colorectal cancer with liver metastases (CRCLM).
Objective: To investigate the clinical outcomes and failure patterns of patients with unresectable cholangiocarcinoma (CC) who had been treated with proton beam therapy (PBT).
This study aimed to clarify the correlation between PET metabolic parameters and CD147 expression, and to evaluate the prognostic value of CD147 expression in resectable lung adenocarcinoma patients.
Durvalumab is the only approved immunotherapy for unresectable stage III LA NSCLC.
Pancreas
Research Hotspot
Pancreas
Journal Scope
